Skip to main content
Equibles

Legato Capital Management LLC

Position in LQDA — Liquidia Corp

CIK 1442641 San Francisco, CA
Back to LQDA Full portfolio

Position in LQDA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,021,314
+$1,096,081 QoQ
Shares Held
25,352
+3.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Legato Capital Management LLC holds $15,423,810 across 11 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KNSA
Kiniksa Pharmaceuticals International, plc
 87,297 $5,582,643
2 LQDA
Liquidia Corp
This page 		25,352 $2,021,314
3 XERS
Xeris Biopharma Holdings, Inc.
 241,341 $1,911,420
4 SIGA
Siga Technologies Inc
 512,039 $1,863,821
5 INDV
Indivior Pharmaceuticals, Inc.
 22,000 $902,660
6 PCRX
Pacira BioSciences, Inc.
 30,668 $778,047
7 AMPH
Amphastar Pharmaceuticals, Inc.
 34,135 $688,844
8 SUPN
Supernus Pharmaceuticals, Inc.
 11,482 $534,027

All Filings in LQDA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,021,314 25,352
2026-03-31 $925,233 24,516